8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________________

FORM 8-K

______________________________ 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 5, 2014

______________________________

LIFEVANTAGE CORPORATION

(Exact name of registrant as specified in its charter)

______________________________

Colorado	001-35647	90-0224471
(State or other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)
9785 S. Monroe Street, Suite 300, Sandy, UT 84070
(Address of Principal Executive Offices and Zip Code)
Registrant’s telephone number, including area code: (801) 432-9000

______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 Results of Operations and Financial Condition.

On August 5, 2014, LifeVantage Corporation (the “Company”) issued a press release announcing its preliminary financial results for the fiscal quarter and fiscal year ended June 30, 2014. A copy of the Company’s press release is attached as Exhibit 99.1 to this report and incorporated by reference.

The information furnished in this Item 2.02 and the exhibit hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.

(d)    Exhibits

Exhibit No.	Description
99.1	Press release issued by the Company on August 5, 2014 announcing its preliminary financial results for the fiscal quarter and fiscal year ended June 30, 2014.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: August 5, 2014 LIFEVANTAGE CORPORATION By: /s/ Rob Cutler Name: Rob Cutler Title: General Counsel

EX-99.1

LIFEVANTAGE ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL FISCAL 2014 RESULTS

Fourth Quarter Net Revenue Increased 8.8% Over Prior Year Period to $56M

Full Fiscal Year Net Revenue Increased 2.8% Over Fiscal 2013 to $214M

Company Reduced Debt by Approximately $15M During the Fourth Quarter of Fiscal 2014

SALT LAKE CITY, UT, August 5, 2014 (GLOBE NEWSWIRE) — LifeVantage Corporation (NASDAQ: LFVN) today announced preliminary financial results for the fourth quarter and the full fiscal year ended June 30, 2014.

The Company expects fourth quarter revenue of approximately $56 million, representing growth of 8.8% over the prior year period. Revenue growth in the quarter was driven by new product introductions, as well as improvements in the North America, Hong Kong and Philippines markets. Revenue for fiscal 2014 is expected to be approximately $214M, or a 2.8% increase over the prior year. Foreign currency fluctuation negatively impacted full year revenue by approximately $10.4 million, or 5%. For the full fiscal year, the Company’s operating margin is expected to be approximately 9% and diluted earnings per share are expected to be approximately $0.10.

“During the past 9 months, we have implemented a number of strategies and improvements that are enabling our company to return to top line growth. This growth is a direct result of new additions to our senior management team, as well as executing on product, geographic and sales related growth strategies. We believe establishing and executing on our stated strategies has us well positioned for sustaining growth throughout fiscal 2015 and beyond,” stated Douglas C. Robinson, LifeVantage President and Chief Executive Officer.

During the fourth quarter of fiscal 2014, the company reduced its overall debt to approximately $31 million from approximately $46 million. The company ended fiscal 2014 with approximately $20 million in cash and cash equivalents.

The Company expects to release its complete financial results for the fourth quarter and fiscal year ended June 30, 2014 and to provide guidance for fiscal 2015 in connection with its full earnings release and investor call scheduled to be held on September 10, 2014.

About LifeVantage Corporation

LifeVantage Corporation (NASDAQ: LFVN), a leader in Nrf2 science and the maker of Protandim®, the Nrf2 Synergizer® patented dietary supplement, TrueScience^TM Anti-Aging Skin Care Regimen and Canine Health, is a science-based network marketing company. LifeVantage is dedicated to visionary science that looks to transform wellness and anti-aging internally and externally with products that dramatically reduce oxidative stress at the cellular level. The Company was founded in 2003 and is headquartered in Salt Lake City, Utah.

Forward Looking Statements

This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism and satisfaction with current prospects, as well as words such as “believe,” “expects,” “anticipates,” “look forward to,” “should” and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, statements about management’s expectations regarding the company’s performance, initiatives and strategies; statements of current estimates of the company’s revenue, earnings per share, foreign currency impact and other financial items; statements of management’s expectations and plans related to the timing of the release of the company’s full financial results for fiscal 2014 and guidance for fiscal 2015; statements of belief, and statements of assumptions underlying any of the foregoing. Such forward-looking statements are not guarantees of performance and the Company’s actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company’s current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company’s actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, the risk factors discussed in greater detail in the Company’s Annual Report on Form 10-K and its Quarterly Report on Form 10-Q under the caption “Risk Factors,” and in other documents filed by the Company from time to time with the Securities and Exchange Commission. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.

Investor Relations Contact:Cindy England (801) 432-9036
Director of Investor Relations

-or-
John Mills (646) 277-1254

Partner, ICR, INC